By continuing to browse the site you are agreeing to our use of cookies Continue Find out more

A Centre for Healthcare Innovation

Thursday 6th December 2018, Villa Marina, Douglas, Isle of Man

Now in its 6th year, this event has become a regular feature in the Island's biomed sector calendar. It provides an opportunity to catch up with existing sector companies, meet new arrivals and hear out about innovative future healthcare business opportunities being developed globally and on the Isle of Man.

REGISTER ONLINE

Programme

8.15am REGISTRATION and refreshments

9.00am Welcome, Dave Taggart, COO, Glycyx Therapeutics Ltd

9.05am Opening Remarks, Hon Laurence Skelly, MHK, Minister, Department for Enterprise

9.15am Biomed and its place in the Department for Enterprise and Business Agency, Mark Gledhill, Biomed Health & Life Sciences, Department for Enterprise

9.30am How does "Manx Biomed" fit with health care and life sciences? Dave Taggart, COO, Glycyx Therapeutics Ltd

9.45am R&D and the Department for Health and Social Care, progress and live projects, Dr Rebecca Rowley, Head of Research and Development, Department of Health and Social Care and Honorary Fellow at Liverpool University

10.05am Hemp a) Forthcoming IOM Consultation b) Industrial implications and global regulatory update

10.20am Hemp : Whatever your moral or intellectual viewpoint there is an economic and a health story - but it's complicated! Audience open mic, Chair - Dave Taggart, COO, Glycyx Therapeutics Ltd

10.30am BREAK – tea, coffee, biscuits

11.15am China Focus - China and the Isle of Man, potential alliances in health and life sciences

11.45am UVA Pasteurisation

12.05pm Biocore

12.25pm HearScreener

12.45pm Lunch

2.00pm Power Partnerships - why collaboration is a pre requisite for success in health and life sciences

2.20pm Latest developments from existing Manx Biomed businesses, Updates invited from:

TaxaGenomics

Bodystat

Coretech

Glycyx

Health Care Checks

MyZone

Nasaleze

Nimbus

Panacea

Pillar Health

Prometic Bioseparations

Quing

SafeT

SEQ

TaxaGenomics & Pet

Final agenda to be confirmed based on availability

3.50pm Closing remarks, Dave Taggart, COO, Glycyx Therapeutics Ltd

4.00pm REFRESHMENTS

REGISTER ONLINE

Manx Technology Group